# CHGA

## Overview
The CHGA gene encodes the protein chromogranin A, a member of the granin family of acidic secretory proteins, which are predominantly found in the secretory granules of neuroendocrine cells. Chromogranin A serves as a precursor to several bioactive peptides, including vasostatin, pancreastatin, and catestatin, each of which plays distinct roles in physiological processes such as hormone secretion, cardiovascular regulation, and immune response (Taupenot2003The; Bartolomucci2011The). The protein is characterized by its coiled-coil structure and calcium-binding properties, which are essential for its function in secretory granule biogenesis and hormone sorting (Bartolomucci2011The; Helle2010Chromogranins). Chromogranin A's involvement in various cellular interactions and its processing into active peptides underscore its significance in maintaining homeostasis and its potential implications in clinical conditions such as hypertension and metabolic disorders (Mahapatra2008The; Subramanian2017A).

## Structure
The human CHGA gene encodes the chromogranin A (CgA) protein, which is composed of 439 amino acids and has a molecular weight of approximately 48 kDa (D’amico2014Biological; Bartolomucci2011The). The primary structure of CgA includes several dibasic cleavage sites, which are crucial for its processing into various biologically active peptides (D’amico2014Biological). The protein is organized into eight exons and seven introns, with specific exons encoding different functional regions, such as vasostatins and catestatin (Bartolomucci2011The).

CgA exhibits a coiled-coil structure, which is significant for its role in secretory granule biogenesis and aggregation (Bartolomucci2011The; Elias2010Chromogranin). The protein's secondary structure includes an N-terminal disulfide-bonded loop, contributing to its stability and aggregation ability (Elias2010Chromogranin). The tertiary structure involves interactions with phosphatidic acid in the trans-Golgi network, facilitating secretory granule formation (Carmon2020Chromogranin).

Post-translational modifications of CgA include proteolytic cleavages by prohormone convertases, resulting in peptides like vasostatins, pancreastatin, and catestatin, which have various physiological roles (D’amico2014Biological). The protein's acidic nature and calcium-binding properties are also notable, contributing to its function in hormone sorting and secretion (Bartolomucci2011The).

## Function
Chromogranin A (CHGA) is a multifunctional protein involved in several critical processes within healthy human cells. It is primarily found in the secretory granules of neuroendocrine cells, where it plays a key role in the formation and biogenesis of these granules. CHGA acts as a prohormone, being processed into various bioactive peptides, such as vasostatin, pancreastatin, and catestatin, each with distinct physiological functions (Taupenot2003The; Loh2012Chromogranin).

In the endocrine system, CHGA-derived peptides regulate hormone secretion. For example, pancreastatin inhibits insulin release from pancreatic beta cells, affecting glucose metabolism (Taupenot2003The). Catestatin, another peptide derived from CHGA, inhibits catecholamine release, contributing to blood pressure regulation and cardiovascular homeostasis (D’amico2014Biological; Helle2010Chromogranins).

CHGA also influences immune responses and vascular functions. Its peptides exhibit antimicrobial properties and modulate endothelial cell permeability, playing roles in innate immunity and inflammation (Helle2010Chromogranins). The protein is active in various tissues, including the heart and gastrointestinal tract, where it is co-released with other hormones and neurotransmitters, indicating its broad impact on physiological processes (Helle2010Chromogranins).

## Clinical Significance
Mutations and alterations in the CHGA gene, which encodes Chromogranin A, have significant clinical implications, particularly in the context of hypertension and related cardiovascular disorders. Variations in the CHGA gene, such as single nucleotide polymorphisms (SNPs), are associated with hypertension and hypertensive renal disease. These genetic variations can affect CHGA expression and function, influencing blood pressure regulation and autonomic function (Mahapatra2017Naturally; Wen2004Both).

The Gly364Ser variant in the catestatin region of CHGA is linked to changes in autonomic activity and blood pressure regulation. This variant enhances baroreceptor sensitivity and reduces catecholamine secretion, potentially offering a protective effect against hypertension, particularly in men (Rao2007Catecholamine).

Altered CHGA expression is also implicated in cardiometabolic disorders. The Hap2 variant of the CHGA promoter increases CHGA expression, leading to elevated plasma levels and associated risks for conditions like insulin resistance and inflammation, which contribute to elevated blood glucose and BMI (Subramanian2017A).

Overall, the CHGA gene plays a crucial role in the pathogenesis of hypertension and other metabolic disorders, with genetic variations and expression levels serving as potential biomarkers and therapeutic targets (Mahapatra2005Hypertension; Subramanian2017A).

## Interactions
Chromogranin A (CHGA) is involved in various protein interactions crucial for its role in the regulated secretory pathway of neuroendocrine cells. It interacts with secretogranin III (SgIII) and carboxypeptidase E (CPE) to facilitate the sorting of peptide hormones to secretory granules. SgIII targets CHGA multimeric complexes to the regulated secretory pathway, while CPE aids in the budding of immature secretory granules (Elias2010Chromogranin).

CHGA also interacts with the trans-Golgi proteins SCLIP (STMN3) and SCG10 (STMN2), which are essential for the formation and maturation of chromaffin granules. These interactions are mediated by coiled-coil domains and are crucial for the typical transmitter storage and release from chromaffin cells (Mahapatra2008The). The interaction with SCLIP and SCG10 is confirmed through co-immunoprecipitation experiments, indicating specific binding in the Golgi apparatus (Mahapatra2008The).

CHGA's N-terminal disulfide-bonded loop is essential for its homodimerization, which is critical for sorting to secretory granules. This loop mediates interactions at mildly acidic pH levels, characteristic of the trans-Golgi network (Thiele1998The). These interactions highlight CHGA's role in the biogenesis and function of secretory granules.


## References


[1. (Mahapatra2017Naturally) Nitish R. Mahapatra, Sajalendu Ghosh, Manjula Mahata, Gautam K. Bandyopadhyay, and Sushil K. Mahata. Naturally Occurring Single Nucleotide Polymorphisms in Human Chromogranin A (CHGA) Gene: Association with Hypertension and Associated Diseases, pages 195–211. Springer International Publishing, 2017. URL: http://dx.doi.org/10.1007/978-3-319-58338-9_12, doi:10.1007/978-3-319-58338-9_12. This article has 0 citations.](https://doi.org/10.1007/978-3-319-58338-9_12)

[2. (Mahapatra2005Hypertension) Nitish R. Mahapatra, Daniel T. O’Connor, Sucheta M. Vaingankar, Amiya P. Sinha Hikim, Manjula Mahata, Saugata Ray, Eugenie Staite, Hongjiang Wu, Yusu Gu, Nancy Dalton, Brian P. Kennedy, Michael G. Ziegler, John Ross, and Sushil K. Mahata. Hypertension from targeted ablation of chromogranin a can be rescued by the human ortholog. Journal of Clinical Investigation, 115(7):1942–1952, July 2005. URL: http://dx.doi.org/10.1172/jci24354, doi:10.1172/jci24354. This article has 261 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci24354)

[3. (Elias2010Chromogranin) Salah Elias, Charlène Delestre, Maite Courel, Youssef Anouar, and Maite Montero-Hadjadje. Chromogranin a as a crucial factor in the sorting of peptide hormones to secretory granules. Cellular and Molecular Neurobiology, 30(8):1189–1195, November 2010. URL: http://dx.doi.org/10.1007/s10571-010-9595-8, doi:10.1007/s10571-010-9595-8. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10571-010-9595-8)

[4. (Taupenot2003The) Laurent Taupenot, Kimberly L. Harper, and Daniel T. O’Connor. The chromogranin–secretogranin family. New England Journal of Medicine, 348(12):1134–1149, March 2003. URL: http://dx.doi.org/10.1056/nejmra021405, doi:10.1056/nejmra021405. This article has 667 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1056/nejmra021405)

[5. (Rao2007Catecholamine) Fangwen Rao, Gen Wen, Jiaur R. Gayen, Madhusudan Das, Sucheta M. Vaingankar, Brinda K. Rana, Manjula Mahata, Brian P. Kennedy, Rany M. Salem, Mats Stridsberg, Kenneth Abel, Douglas W. Smith, Eleazar Eskin, Nicholas J. Schork, Bruce A. Hamilton, Michael G. Ziegler, Sushil K. Mahata, and Daniel T. O’Connor. Catecholamine release–inhibitory peptide catestatin (chromogranin a 352–372 ): naturally occurring amino acid variant gly364ser causes profound changes in human autonomic activity and alters risk for hypertension. Circulation, 115(17):2271–2281, May 2007. URL: http://dx.doi.org/10.1161/circulationaha.106.628859, doi:10.1161/circulationaha.106.628859. This article has 93 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1161/circulationaha.106.628859)

[6. (Subramanian2017A) Lakshmi Subramanian, Abrar A. Khan, Prasanna K.R. Allu, Malapaka Kiranmayi, Bhavani S. Sahu, Saurabh Sharma, Madhu Khullar, Ajit S. Mullasari, and Nitish R. Mahapatra. A haplotype variant of the human chromogranin a gene (chga) promoter increases chga expression and the risk for cardiometabolic disorders. Journal of Biological Chemistry, 292(34):13970–13985, August 2017. URL: http://dx.doi.org/10.1074/jbc.m117.778134, doi:10.1074/jbc.m117.778134. This article has 5 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m117.778134)

[7. (Wen2004Both) Gen Wen, Sushil K. Mahata, Peter Cadman, Manjula Mahata, Sajalendu Ghosh, Nitish R. Mahapatra, Fangwen Rao, Mats Stridsberg, Douglas W. Smith, Payam Mahboubi, Nicholas J. Schork, Daniel T. O’Connor, and Bruce A. Hamilton. Both rare and common polymorphisms contribute functional variation at chga, a regulator of catecholamine physiology. The American Journal of Human Genetics, 74(2):197–207, February 2004. URL: http://dx.doi.org/10.1086/381399, doi:10.1086/381399. This article has 91 citations.](https://doi.org/10.1086/381399)

[8. (Loh2012Chromogranin) Y. Peng Loh, Yong Cheng, Sushil K. Mahata, Angelo Corti, and Bruno Tota. Chromogranin a and derived peptides in health and disease. Journal of Molecular Neuroscience, 48(2):347–356, March 2012. URL: http://dx.doi.org/10.1007/s12031-012-9728-2, doi:10.1007/s12031-012-9728-2. This article has 68 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12031-012-9728-2)

[9. (Bartolomucci2011The) Alessandro Bartolomucci, Roberta Possenti, Sushil K. Mahata, Reiner Fischer-Colbrie, Y. Peng Loh, and Stephen R. J. Salton. The extended granin family: structure, function, and biomedical implications. Endocrine Reviews, 32(6):755–797, August 2011. URL: http://dx.doi.org/10.1210/er.2010-0027, doi:10.1210/er.2010-0027. This article has 254 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1210/er.2010-0027)

[10. (Helle2010Chromogranins) Karen B. Helle. Chromogranins A and B and Secretogranin II as Prohormones for Regulatory Peptides from the Diffuse Neuroendocrine System, pages 45–62. Springer Berlin Heidelberg, 2010. URL: http://dx.doi.org/10.1007/400_2009_26, doi:10.1007/400_2009_26. This article has 9 citations.](https://doi.org/10.1007/400_2009_26)

[11. (Carmon2020Chromogranin) Ophélie Carmon, Fanny Laguerre, Lina Riachy, Charlène Delestre‐Delacour, Qili Wang, Emeline Tanguy, Lydie Jeandel, Dorthe Cartier, Tamou Thahouly, Anne‐Marie Haeberlé, Laetitia Fouillen, Olivier Rezazgui, Damien Schapman, Alexandre Haefelé, Yannick Goumon, Ludovic Galas, Pierre‐Yves Renard, Stéphane Alexandre, Nicolas Vitale, Youssef Anouar, and Maité Montero‐Hadjadje. Chromogranin a preferential interaction with golgi phosphatidic acid induces membrane deformation and contributes to secretory granule biogenesis. The FASEB Journal, 34(5):6769–6790, March 2020. URL: http://dx.doi.org/10.1096/fj.202000074r, doi:10.1096/fj.202000074r. This article has 15 citations.](https://doi.org/10.1096/fj.202000074r)

[12. (Mahapatra2008The) Nitish R. Mahapatra, Laurent Taupenot, Maite Courel, Sushil K. Mahata, and Daniel T. O’Connor. The trans-golgi proteins sclip and scg10 interact with chromogranin a to regulate neuroendocrine secretion. Biochemistry, 47(27):7167–7178, June 2008. URL: http://dx.doi.org/10.1021/bi7019996, doi:10.1021/bi7019996. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi7019996)

[13. (D’amico2014Biological) Maria Angela D’amico, Barbara Ghinassi, Pascal Izzicupo, Lamberto Manzoli, and A Di Baldassarre. Biological function and clinical relevance of chromogranin a and derived peptides. Endocrine Connections, 3(2):R45–R54, June 2014. URL: http://dx.doi.org/10.1530/ec-14-0027, doi:10.1530/ec-14-0027. This article has 89 citations and is from a peer-reviewed journal.](https://doi.org/10.1530/ec-14-0027)

[14. (Thiele1998The) Christoph Thiele and Wieland B. Huttner. The disulfide-bonded loop of chromogranins, which is essential for sorting to secretory granules, mediates homodimerization. Journal of Biological Chemistry, 273(2):1223–1231, January 1998. URL: http://dx.doi.org/10.1074/jbc.273.2.1223, doi:10.1074/jbc.273.2.1223. This article has 59 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.273.2.1223)